Researcher
Sigrid Stroobants
- Keywords:Medicine
- Disciplines:Cancer diagnosis, Biomarker evaluation, Nuclear imaging, Neurosciences not elsewhere classified
Affiliations
- Molecular Imaging and Radiology (MIRA) (Research group)
Responsible
From1 Jan 2019 → Today - Molecular Imaging, Pathology, Radiotherapy & Oncology (MIPRO) (Research group)
Member
From1 Sep 2008 → 31 Dec 2018
Infrastructure
1 - 1 of 1
- Flanders BioImaging (FBI/EBI) (Consortium partner)
Projects
1 - 10 of 29
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE).From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Diagnostic and theranostic targeting of fibroblast activation protein (FAP) with goed nanoparticles decorated with FAPIs and FAPI fragments.From1 Jan 2023 → TodayFunding: Foundations, funds and other with scientific goal
- Development of theranostic ligands for fibroblast activation protein with improved pharmacokinetic profile.From1 Sep 2022 → 31 Aug 2023Funding: IOF - technology validation in lab
- Biomarker and therapy development through in vivo Molecular Imaging of small animals.From1 Jun 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- Validation of autophagy induction as a therapeutic strategy: from drug discovery and preclinical evaluation to safety investigation and biomarker research.From1 Jan 2021 → TodayFunding: BOF - projects
- Positron emission tomography combined with innovative laboratory techniques for improved risk and disease assessment in myeloma.From1 Jan 2021 → TodayFunding: FWO Applied Biomedical Research (TBM)
- IMARK. Network for image-based biomarker discovery and evaluationFrom1 Jan 2021 → TodayFunding: IOF - mandates
- Improved PET probes for predicting and imaging immunotherapy responses.From1 Oct 2020 → 30 Sep 2023Funding: FWO senior postdoctoral fellowship
- Biopharmaceutical optimization of PET-diagnostic tools targeting fibroblast activation protein (FAP).From1 May 2020 → 30 Sep 2021Funding: IOF - technology validation in lab
- High-resolution slide scanner for digital histopathological phenotyping in health and disease.From1 Jan 2020 → 31 Dec 2021Funding: BOF - scientific equipment program
Publications
1 - 10 of 155
- Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)(2024)
Authors: Magdalena Mileva, Elisabeth G.E. de Vries, Thomas Guiot, Zena Wimana, Anne-Leen Deleu, Carolien P. Schroder, Yolene Lefebvre, Marianne Paesmans, Sigrid Stroobants, Manon Huizing, et al.
Pages: 1 - 10 - Design, synthesis, and evaluation of Trans-cyclooctene (TCO) and cis-dioxolane fused TCO (d-TCO) probes for bioorthogonal pretargeted PET imaging(2024)
Authors: Karuna Adhikari, Koen Augustyns, Filipe Elvas, Sigrid Stroobants
Number of pages: 244 - ¹⁸F-AlF-NOTA-octreotide outperforms ⁶⁸Ga-DOTA-TATE/-NOC PET in neuroendocrine tumor patients(2023)
Authors: Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, et al.
Pages: 632 - 638 - Prospective comparison of [¹⁸F]AlF-NOTA-octreotide PET/MRI to [⁶⁸Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Lennert Boeckxstaens, Elin Pauwels, Vincent Vandecaveye, Wies Deckers, Frederik Cleeren, Jeroen Dekervel, Timon Vandamme, Kim Serdons, Michel Koole, Guy Bormans, et al.
Pages: 1 - 13 - Characterization of structurally diverse ¹⁸F-labeled d-TCO derivatives as a PET probe for bioorthogonal pretargeted imaging(2023)
Authors: Karuna Adhikari, Christel Vangestel, Pieter Van Der Veken, Sigrid Stroobants, Filipe Elvas, Koen Augustyns
Pages: 38252 - 38262 - MRI Apparent Diffusion Coefficient (ADC) as a biomarker of tumour response(2023)
Authors: Alan Jackson, Ryan Pathak, Nandita M. deSouza, Yan Liu, Bart K.M. Jacobs, Saskia Litiere, Maria Urbanowicz-Nijaki, Catherine Julie, Arturo Chiti, Jens Theysohn, et al.
Pages: 1 - 15 - The clinical value of combined FDG-PET/CT imaging in response evaluation after chemoradiotherapy in patients with potentially operable locally advanced head and neck squamous cell carcinoma(2023)
Authors: Nils Helsen, Sigrid Stroobants, Tim Van den Wyngaert, Laurens Carp
Number of pages: 148 - ¹⁸F-FDG and ¹⁸F-FLT uptake profiles for breast cancer cell lines treated with targeted PI3K/Akt/mTOR therapies(2023)
Authors: Yanina Dockx, Christel Vangestel, Sven De Bruycker, Tim Van den Wyngaert, Manon Huizing, Steven Staelens, Sigrid Stroobants
Pages: 51 - 61 - Synaptic vesicle glycoprotein 2A is affected in the CNS of Huntington’s Disease mice and post-mortem human HD brain(2022)
Authors: Daniele Bertoglio, Jeroen Verhaeghe, Leonie Wyffels, Alan Miranda Menchaca, Sigrid Stroobants, Ladislav Mrzljak, Celia Dominguez, Mette Skinbjerg, Jonathan Bard, Longbin Liu, et al.
Pages: 942 - 947 - Quantification of metabotropic glutamate receptor 5 availability with both [¹¹C]ABP688 and [¹⁸F]FPEB positron emission tomography in the Sapap3 knockout mouse model for obsessive-compulsive–like behavior(2022)
Authors: Dorien Glorie, Jeroen Verhaeghe, Alan Miranda Menchaca, Sigrid Stroobants, Steven Staelens
Pages: 607 - 615
Patents
1 - 3 of 3